Uttarakhand's Dehradun district on Sunday reported 20 new cases of black fungus and the death of three patients during treatment.
According to a bulletin of the Health Department, the total number of black fungus patients in the state has gone up to 299, 47 patients have died and 18 patients have recovered so far.
The All India Institute of Medical Sciences (AIIMS) Rishikesh has the highest number of patients (195) undergoing treatment.
Mucormycosis or black fungus is a complication caused by a fungal infection. People catch mucormycosis by coming in contact with the fungal spores in the environment. It can also develop on the skin after the fungus enters the skin through a cut, scrape, burn, or other types of skin trauma, as per the Union Health Ministry. The disease is being detected among patients who are recovering or have recovered from COVID-19. Moreover, anyone who is diabetic and whose immune system is not functioning well needs to be on the guard against this.
Looking at the rising cases of Mucormycosis or 'black fungus', the Union Health Ministry had last month said the availability of Amphotericin-B, the key drug to treat the deadly disease is now being increased and the ministry is in touch with five additional manufacturers.
Several states including Madhya Pradesh, Rajasthan, Bihar, Gujarat, Punjab, Haryana, Karnataka, Odisha, Telangana and Tamil Nadu have declared it a 'notifiable' disease under the Epidemic Diseases Act, thereby making it mandatory to report every Mucormycosis case to the state government.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU